Additionally, several key clinical trial readouts delivered compelling data across multiple indications, for example (see Figure 1): Semaglutide : STEP-HFpEF (functional benefits in HFpEF), STEP-9 (pain reduction in knee osteoarthritis), STEP-10 (reversion to normoglycaemia in pre-diabetic, obese patients), ESSENCE (resolution of MASH, improvement in fibrosis) Tirzepatide : SUMMIT (risk reduction in HFpEF outcomes
Weight loss strongly correlates with increased testosterone in many studies
GLP-1 use is associated with reduced risk of Alzheimer's disease, dementia, and seizures ^8
For tirzepatide users, constipation management , diarrhea duration , and fatigue follow similar patterns
Some patients explore switching from semaglutide to tirzepatide and need to manage shipping logistics for both medications during the transition period
Learn about semaglutide Tirzepatide Zepbound / Mounjaro Dual GIP/GLP-1 receptor agonist